Biodexa Pharmaceuticals (BDRX) FCF Payout Ratio (2019 - 2022)
Biodexa Pharmaceuticals (BDRX) posted FCF Payout Ratio of 194.64 for Q4 2022, little changed sequentially from 194.64 in Q3 2022, and up 775.03% YoY from 22.24 in Q4 2021.
Biodexa Pharmaceuticals (BDRX) FCF Payout Ratio (2019 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported FCF Payout Ratio for 4 years, with the latest figure at 194.64 in Q4 2022.
- Quarterly FCF Payout Ratio rose 775.03% year-over-year to 194.64 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 80.72 (up 4743.7% YoY) and the FY2022 annual result came in at 0.92, down 24.4% from the prior year.
- FCF Payout Ratio held at 194.64 in Q4 2022 per BDRX's latest filing, from 194.64 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 194.64 in Q4 2022 and troughed at 1.98 in Q4 2019.
- A 4-year average of 58.12 and a median of 0.62 in 2020 frame the typical range for FCF Payout Ratio.
- The sharpest annual moves came in 2021 and 2022: FCF Payout Ratio slumped 132.9% in 2021, then jumped 13614.36% in 2022.
- Over 4 years, FCF Payout Ratio stood at 1.98 in 2019, then jumped by 68.72% to 0.62 in 2020, then surged by 3697.08% to 22.24 in 2021, then surged by 775.03% to 194.64 in 2022.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 194.64, 194.64, and 22.24 for Q4 2022, Q3 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 0.07 |
| 10 | Biodexa Pharmaceuticals | 64,183.91 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 194.64 |
| Sep 14, 2022 | 194.64 |
| Dec 31, 2021 | 22.24 |
| Sep 17, 2021 | -1.44 |
| Dec 31, 2020 | -0.62 |
| Sep 10, 2020 | -0.62 |
| Dec 31, 2019 | -1.98 |